SK Chemicals conducts Phase 3 clinical trial of cell culture influenza vaccine

Published: 2013-08-29 06:57:00

Updated: 2013-08-29 06:57:00

SK Chemicals said Tuesday that it has carried out Phase 3 clinical tests for its influenza cell culture vaccine using animal cell after it gained the green light from the Ministry of Food and Drug Safety.

According to the company, the clinical trial will be conducted for adults and children in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK